BRAND_ANALYSIS #BIONTECH HEALTH & PHARMA #18 OF 26 IN HEALTH & PHARMA ALIGNED

BioNTech

· Public · Updated 09 Apr 2026 08:47 UTC
#637 of 1208 overall by tension · #18 of 26 in Health & Pharma
12 Aligned
The Balanced
Analysis

The vaccine company collapses from hype to reality: C=46, B=34, -9.87% stock movement, 0.30 sentiment. BioNTech was pandemic hero; now it's struggling pipeline and shareholder disappointment.

IN THE NEWS (70 articles this week)
BioNTech telegraphs closure of Singapore vaccine facility amid efforts to 'align capacity' - Fierce Pharma
BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot - BioSpace
Pfizer and BioNTech Pause Covid Vaccine Study Following Low Enrollment Totals - Pharmaceutical Executive
Cultural Score
46 / 100
Business Score
34 / 100
TENSION▁▃▂▂▂▂▂▂▂▃▂▂▂▁
CULTURAL▄▆▄▄▄▄▄▄▄▅▄▄▄▄
BUSINESS▄▄▂▂▂▂▂▂▂▂▃▃▃▃
Loading...
Wikipedia Momentum 15/40
News Presence 31/35
Search InterestRedistributed to other dimensions
Stock Momentum 12/30
Market Position 16/25
Revenue Growth 3/25
Earnings Health 3/20
Price$92.08
30d Change-9.9%
Market Cap$23.3B
Profit Margin-39.6%
BioNTech's tension is 12. Culture outpacing commerce. sociologyofcapitalism.com/brand/biontech
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/biontech.html" width="320" height="200" frameborder="0"></iframe>